Growth Metrics

CorMedix (CRMD) Net Cash Flow (2016 - 2025)

CorMedix (CRMD) has disclosed Net Cash Flow for 13 consecutive years, with $96.3 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow rose 1695.31% to $96.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $105.1 million through Dec 2025, up 3528.03% year-over-year, with the annual reading at $105.1 million for FY2025, 3528.03% up from the prior year.
  • Net Cash Flow hit $96.3 million in Q4 2025 for CorMedix, up from -$109.9 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $96.3 million in Q4 2025 to a low of -$109.9 million in Q3 2025.
  • Historically, Net Cash Flow has averaged $5.0 million across 5 years, with a median of -$3.1 million in 2021.
  • Biggest YoY gain for Net Cash Flow was 1695.31% in 2025; the steepest drop was 1729.66% in 2025.
  • Year by year, Net Cash Flow stood at -$13.0 million in 2021, then surged by 99.15% to -$111121.0 in 2022, then tumbled by 15990.82% to -$17.9 million in 2023, then soared by 130.01% to $5.4 million in 2024, then surged by 1695.31% to $96.3 million in 2025.
  • Business Quant data shows Net Cash Flow for CRMD at $96.3 million in Q4 2025, -$109.9 million in Q3 2025, and $93.0 million in Q2 2025.